The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients
Crossref DOI link: https://doi.org/10.1007/s00403-014-1533-z
Published Online: 2014-12-24
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
González-Lara, Leire
Batalla, Ana
Coto, Eliecer
Gómez, Juan
Eiris, Noemí
Santos-Juanes, Jorge
Queiro, Rubén
Coto-Segura, Pablo
Text and Data Mining valid from 2014-12-24